Skip to main content
Livermore
Livermore
ZHEN

Stratos Wealth Partners, LTD.

SEC CIK
0001612865
Latest filing
Aug 11, 2026

GALT holding history

Galectin Therapeutics Inc in every 13F filed by Stratos Wealth Partners, LTD., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GALT overviewAll 13F holders of GALTFull Q2 2026 holdings

Shares (Q2 2026)
19,088
Value
$88.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GALT by Stratos Wealth Partners, LTD., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,088$88.6K<0.1%−800−4.0%ReducedHolders
Q1 202619,888$55.5K<0.1%+800+4.2%AddedHolders
Q4 202519,088$79.4K<0.1%−10,962−36.5%ReducedHolders
Q3 202530,050$127.3K<0.1%−30,700−50.5%ReducedHolders
Q2 202560,750$128.2K<0.1%+9,200+17.8%AddedHolders
Q1 202551,550$62.9K<0.1%00.0%UnchangedHolders
Q4 202451,550$66.5K<0.1%+11,100+27.4%AddedHolders
Q3 202440,450$111.2K<0.1%00.0%UnchangedHolders
Q2 202440,450$91.4K<0.1%00.0%UnchangedHolders
Q1 202440,450$96.7K<0.1%00.0%UnchangedHolders
Q4 202340,450$67.1K<0.1%00.0%UnchangedHolders
Q3 202340,450$77.7K<0.1%00.0%UnchangedHolders
Q2 202340,450$58.2K<0.1%00.0%UnchangedHolders
Q1 202340,450$84.9K<0.1%−500−1.2%ReducedHolders
Q4 202240,950$46.3K<0.1%00.0%UnchangedHolders
Q3 202240,950$67.0K<0.1%00.0%UnchangedHolders
Q2 202240,950$54.0K<0.1%00.0%UnchangedHolders
Q1 202240,950$66.0K<0.1%00.0%UnchangedHolders
Q4 202140,950$85.0K<0.1%00.0%UnchangedHolders
Q3 202140,950$159.0K<0.1%00.0%UnchangedHolders
Q2 202140,950$131.0K<0.1%00.0%UnchangedHolders
Q1 202140,950$89.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.